SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-055979
Filing Date
2017-11-03
Accepted
2017-11-03 08:31:22
Documents
41
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv477705_10q.htm 10-Q 536263
2 EXHIBIT 10.1 tv477705_ex10-1.htm EX-10.1 13662
3 EXHIBIT 31.1 tv477705_ex31-1.htm EX-31.1 10070
4 EXHIBIT 31.2 tv477705_ex31-2.htm EX-31.2 10318
5 EXHIBIT 32.1 tv477705_ex32-1.htm EX-32.1 3851
6 EXHIBIT 32.2 tv477705_ex32-2.htm EX-32.2 3768
  Complete submission text file 0001144204-17-055979.txt   2569526

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ck0001651407-20170930.xml EX-101.INS 420901
8 XBRL TAXONOMY EXTENSION SCHEMA ck0001651407-20170930.xsd EX-101.SCH 24930
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001651407-20170930_cal.xml EX-101.CAL 18030
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001651407-20170930_def.xml EX-101.DEF 175760
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001651407-20170930_lab.xml EX-101.LAB 182666
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001651407-20170930_pre.xml EX-101.PRE 198361
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38128 | Film No.: 171174720
SIC: 2834 Pharmaceutical Preparations